The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative-Reference-Cited by-同舟云学术

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Published:2014-08-21 Issue:6 Volume:10 Page:808-817
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Molinuevo José Luis¹,Blennow Kaj²,Dubois Bruno³,Engelborghs Sebastiaan⁴⁵,Lewczuk Piotr⁶,Perret‐Liaudet Armand⁷,Teunissen Charlotte E.⁸,Parnetti Lucilla⁹

Affiliation:

1. Alzheimer's Disease and Other Cognitive Disorders UnitHospital Clinic i Universitari, IDIBAPS and Barcelona Beta Research CentrePasqual Maragall FoundationBarcelonaSpain

2. Clinical Neurochemistry Laboratory, Department of Psychiatry and NeurochemistryInstitute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of GothenburgMölndalSweden

3. Centre des Maladies Cognitives et Comportementales, Hôpital de la Salpêtrière, AP‐HPInstitute of Brain and Spinal Cord (ICM), UMR‐S975Université Pierre et Marie Curie‐Paris 6ParisFrance

4. Department of Neurology and Memory ClinicHospital Network Antwerp (ZNA)Middelheim and Hoge BeukenAntwerpBelgium

5. Reference Centre for Biological Markers of Dementia (BIODEM)Institute Born‐Bunge, University of AntwerpAntwerpBelgium

6. Department of Psychiatry and PsychotherapyUniversitätsklinikum Erlangen and Friedrich‐Alexander Universität Erlangen‐NürnbergErlangenGermany

7. Centre for Memory Resources and Research (CMRR)Neurobiology Laboratory, GHE, Hôpitaux de LyonUniversité Lyon 1, CNRS UMR5292, INSERM U1028LyonFrance

8. Neurochemistry Laboratory and BiobankDepartment of Clinical Chemistry, VU University Medical CenterAmsterdamThe Netherlands

9. Centre for Memory Disturbances and Alzheimer's Centre, Section of NeurologyUniversity of PerugiaPerugiaItaly

Funder

Alzheimer Research Foundation

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2014.03.003

Reference79 articles.

1. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Safety and Acceptability of the Research Lumbar Puncture

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Prevalence of Beta-Amyloid Pathology and Alzheimer’s Disease Co-Pathology in Idiopathic Normal-Pressure Hydrocephalus—Association with Neuropsychological Features;Biomedicines;2024-08-20

2. Different meanings of a three-point decline in MMSE score in Alzheimer's disease and depressive disorder;BJPsych Open;2024-08-08

3. The Australian Traumatic Brain Injury Initiative: Statement of Working Principles and Rapid Review of Methods to Define Data Dictionaries for Neurological Conditions;Neurotrauma Reports;2024-04-01

4. Early‐phase amyloid PET reproduces metabolic signatures of cognitive decline in Parkinson's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-04

5. Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure;International Journal of Molecular Sciences;2024-01-10